This study is looking at whether adding Bone Marrow Aspirate (BMA) injections to standard knee arthroscopy surgery can improve outcomes for people with knee injuries like meniscal tears or cartilage damage. You might be eligible if you are between 18 and 64 years old and need knee arthroscopy for these conditions, with specific grades of arthritis (Kellgren-Lawrence grade 0) and cartilage damage (Outerbridge grade 2 or lower). The study will enroll 50 participants. Success will be measured by changes in your Knee Injury and Osteoarthritis Outcome Score (KOOS) after 12 months. The current status of this study is unclear.

Study design

This is an interventional study with 50 participants. You would be randomly assigned to one of two groups: one receiving arthroscopic debridement surgery with Bone Marrow Aspirate (BMA) and the other receiving the surgery with a saline injection.

What's involved

You would undergo knee arthroscopic debridement surgery. If in the BMA group, a small amount of bone marrow would be taken from your hip bone during surgery.

Compensation

Not stated in the trial record.

Follow-up

Your knee health will be assessed at a 12-month follow-up after the surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.